PortfoliosLab logoPortfoliosLab logo

ProShares Ultra Nasdaq Biotechnology (BIB) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIB. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIB

BIB charges 0.95% annually. There are 92 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.


Best Risk-Adjusted Alternatives to BIB

BIB has a PortfoliosLab risk / return rank of 80. There are 21 ETFs in the Leveraged Equities category with higher risk-adjusted ranks, going as high as 98.


Top Performing BIB Alternatives (YTD)

BIB is at 12.50% YTD. There are 115 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 780.13%.


Lowest Volatility Alternatives to BIB

BIB has 40.43% 1-year volatility. There are 84 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.83%.


Lowest Drawdown Alternatives to BIB

BIB has a 1-year max drawdown of -16.92%. There are 16 ETFs in the Leveraged Equities category with shallower 1-year drawdowns, going as shallow as -1.72%.


Other ETFs from ProShares

The 10 most viewed ProShares ETFs shown here include TQQQ, BITO, QLD and span 10 categories. AUM among these funds goes as high as $40B.


Often Compared With BIB

Investors most often compare BIB with XBI, BIS, LABU. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
SPDR S&P Biotech ETFHealth & Biotech Equities
90
20.70%
8.62BFeb 2006BIB vs XBI
ProShares UltraShort Nasdaq BiotechnologyLeveraged Equities
0
-17.93%
2.70MApr 2010BIB vs BIS
Direxion Daily S&P Biotech Bull 3x SharesLeveraged Equities
91
47.57%
567.89MMay 2015BIB vs LABU
VanEck Vectors Biotech ETFHealth & Biotech Equities
44
0.83%
374.51MDec 2011BIB vs BBH
Amgen Inc.
74
7.56%
BIB vs AMGN
Invesco Nasdaq Biotechnology ETFHealth & Biotech Equities
83
8.67%
68.94MJun 2021BIB vs IBBQ
ARK Genomic Revolution Multi-Sector ETFHealth & Biotech Equities, Actively Managed
36
24.30%
1.31BOct 2014BIB vs ARKG
State Street SPDR S&P 500 ETFS&P 500
59
8.15%
765.27BJan 1993BIB vs SPY
Nasdaq, Inc.
34
-14.50%
BIB vs NDAQ
ProShares Ultra Health CareLeveraged Equities
26
-5.37%
69.76MJan 2007BIB vs RXL
Virtus LifeSci Biotech Clinical Trials ETFHealth & Biotech Equities
95
25.75%
40.93MDec 2014BIB vs BBC
YieldMax RDDT Option Income Strategy ETFDerivative Income
-23.45%
13.41MSep 2025BIB vs RDYY
Direxion Daily Pharmaceutical & Medical Bull 3X Sh...Leveraged Equities
86
26.72%
14.48MNov 2017BIB vs PILL
Invesco DWA Healthcare Momentum ETFMomentum, Health & Biotech Equities
66
10.66%
120.78MOct 2006BIB vs PTH
Vanguard Total Stock Market ETFLarge Cap Blend Equities
59
8.82%
2.30TMay 2001BIB vs VTI
Amplify Blockchain Technology ETFBlockchain, Technology Equities
20
14.77%
1.24BJan 2018BIB vs BLOK
VanEck Semiconductor ETFSemiconductors, Technology Equities
94
72.73%
84.54BDec 2011BIB vs SMH
Leverage Shares 2X Long AMD Daily ETFLeveraged Equities
94
329.09%
40.80MJan 2025BIB vs AMDG
Direxion Daily South Korea Bull 3X SharesLeveraged Equities
93
285.56%
2.15BApr 2013BIB vs KORU
Direxion Daily MU Bull 2X SharesLeveraged Equities, Semiconductors6.59BOct 2024BIB vs MUU

Compare BIB with Any Fund or Stock

Compare BIB with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIB with funds that move differently

ProShares Ultra Nasdaq Biotechnology alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIB.

Explore BIB Diversifiers